Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.

Arthritis and rheumatism

Volumn 64, Issue 4, 2012, Pages 1035-1045

  Connolly, Mary ^a   Mullan, Ronan H ^b   McCormick, Jennifer ^b   Matthews, Clare ^b   Sullivan, Owen ^b   Kennedy, Aisling ^b   FitzGerald, Oliver ^b   Poole, A Robin ^b   Bresnihan, Barry ^b   Veale, Douglas J ^b   Fearon, Ursula ^b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; COLLAGEN TYPE 2; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MATRIX METALLOPROTEINASE; SERUM AMYLOID A; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ADOLESCENT; ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; FOOT; HAND JOINT; HUMAN; MALE; METABOLISM; MIDDLE AGED; RADIOGRAPHY; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM;

ADOLESCENT; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COLLAGEN TYPE II; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FOOT JOINTS; HAND JOINTS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; SERUM AMYLOID A PROTEIN; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866148181     PISSN: None     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.33455     Document Type: Article

References (0)